Sera Prognostics (SERA) EBITDA Margin Growth (5y) (2025 - 2026)
Sera Prognostics (SERA) EBITDA Margin Growth (5y) (2025 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.88 Bn | 197.28 Bn | 7.27 Bn |
| 2 | Stryker | 126.34 Bn | 122.87 Bn | 4.50 Bn |
| 3 | Medtronic | 119.78 Bn | 110.56 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.35 Bn | 73.81 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.73 Bn | 47.47 Bn | 1.35 Bn |
| 6 | Dexcom | 35.36 Bn | 33.41 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.85 Bn | 31.74 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.23 Bn | 22.91 Bn | 4.55 Bn |
| 9 | Steris | 23.23 Bn | 22.75 Bn | 684.20 Mn |
| 10 | Sera Prognostics | 108.53 Mn | 108.53 Mn | -20,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 355,833.00 |
| Mar 31, 2026 | -2.05 Mn |
| Dec 31, 2025 | -1.03 Mn |
| Sep 30, 2025 | 3.68 Mn |
| Jun 30, 2025 | 1.65 Mn |